把供应商、客户、政府合同、重大协议、项目与产能做成逐条可核验的关系账本。 每条边都保留方向、证据等级、原文、日期和官方链接，不把“属于同一产业链”当成真实供销关系。
| 关系方向 | 关系 / 状态 | 金额 / 产能 | 证据 | 披露日期 | 详情 |
|---|---|---|---|---|---|
政府合同 已完成 置信度 98% | $191.0K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $191,017 from Department of Veterans Affairs. TYVASO USAspending.gov |
结构化政府合同或两端官方记录；金额与合同编号可回到原始记录核验。
SEC、公司 IR 或 EIA 正式材料点名对手方、项目或设施；方向不明确时单独标注。
海关、提单等物流信号只能作为线索，不单独写成已确认供销事实。
| 2026-07-30 |
| 核验证据 |
United Therapeutics CorporationUTHR Department of Veterans Affairs EMERGENCY TYVASO MEDICATION REFILLS | 政府合同 已完成 置信度 98% | $207.7K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $207,667 from Department of Veterans Affairs. EMERGENCY TYVASO MEDICATION REFILLS USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $298.6K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $298,648 from Department of Veterans Affairs. TYVASO USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $366.3K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $366,330 from Department of Veterans Affairs. TYVASO MEDICATION USAspending.gov | 2026-07-30 | 核验证据 |
United Therapeutics CorporationUTHR Department of Veterans Affairs (QTY 18) TREPROSTINIL 0.6MG/ML SOLN,INHL,REFILL KIT - TYVASO 0.6MG/ML REFILL KIT NDC#: 66302-0206-02 | 政府合同 已完成 置信度 98% | $264.5K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $264,485 from Department of Veterans Affairs. (QTY 18) TREPROSTINIL 0.6MG/ML SOLN,INHL,REFILL KIT - TYVASO 0.6MG/ML REFILL KIT NDC#: 66302-0206-02 USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $296.0K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $296,031 from Department of Veterans Affairs. EO14042 TYVASCO USAspending.gov | 2026-07-30 | 核验证据 |
项目运营 进行中 置信度 92% | — 3 MW | B · 单方官方披露 United Therapeutics Corporation reports XPF Solar Field generator PV1: 3 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |